MedTrace Logo

Clinical Evaluation of Mediguide System in Cardiac Resynchronization Therapy (CRT) Implants

NCT01519739 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2019-10-30

No results posted yet for this study

Summary

The purpose of this study is to evaluate the safety and performance of the MediGuide™ system during CRT implants.

Conditions

Interventions

DEVICE

MediGuide™

MediGuide™ system will be used to guide CRT implants

Sponsors & Collaborators

  • Abbott Medical Devices

    lead INDUSTRY

Principal Investigators

  • Gerhard Hindricks, MD · Herzzentrum Leipzig GmbH

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-01-31
Primary Completion
2012-05-31
Completion
2012-11-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01519739 on ClinicalTrials.gov